Factor H binds to the hypervariable region of many Streptococcus pyogenes M proteins but does not promote phagocytosis resistance or acute virulence. 2013

Mattias C U Gustafsson, and Jonas Lannergård, and O Rickard Nilsson, and Bodil M Kristensen, and John E Olsen, and Claire L Harris, and Rafael L Ufret-Vincenty, and Margaretha Stålhammar-Carlemalm, and Gunnar Lindahl
Medical Microbiology Section, Department of Laboratory Medicine, Medical Faculty, Lund University, Lund, Sweden.

Many pathogens express a surface protein that binds the human complement regulator factor H (FH), as first described for Streptococcus pyogenes and the antiphagocytic M6 protein. It is commonly assumed that FH recruited to an M protein enhances virulence by protecting the bacteria against complement deposition and phagocytosis, but the role of FH-binding in S. pyogenes pathogenesis has remained unclear and controversial. Here, we studied seven purified M proteins for ability to bind FH and found that FH binds to the M5, M6 and M18 proteins but not the M1, M3, M4 and M22 proteins. Extensive immunochemical analysis indicated that FH binds solely to the hypervariable region (HVR) of an M protein, suggesting that selection has favored the ability of certain HVRs to bind FH. These FH-binding HVRs could be studied as isolated polypeptides that retain ability to bind FH, implying that an FH-binding HVR represents a distinct ligand-binding domain. The isolated HVRs specifically interacted with FH among all human serum proteins, interacted with the same region in FH and showed species specificity, but exhibited little or no antigenic cross-reactivity. Although these findings suggested that FH recruited to an M protein promotes virulence, studies in transgenic mice did not demonstrate a role for bound FH during acute infection. Moreover, phagocytosis tests indicated that ability to bind FH is neither sufficient nor necessary for S. pyogenes to resist killing in whole human blood. While these data shed new light on the HVR of M proteins, they suggest that FH-binding may affect S. pyogenes virulence by mechanisms not assessed in currently used model systems.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D001425 Bacterial Outer Membrane Proteins Proteins isolated from the outer membrane of Gram-negative bacteria. OMP Proteins,Outer Membrane Proteins, Bacterial,Outer Membrane Lipoproteins, Bacterial

Related Publications

Mattias C U Gustafsson, and Jonas Lannergård, and O Rickard Nilsson, and Bodil M Kristensen, and John E Olsen, and Claire L Harris, and Rafael L Ufret-Vincenty, and Margaretha Stålhammar-Carlemalm, and Gunnar Lindahl
October 2001, Molecular microbiology,
Mattias C U Gustafsson, and Jonas Lannergård, and O Rickard Nilsson, and Bodil M Kristensen, and John E Olsen, and Claire L Harris, and Rafael L Ufret-Vincenty, and Margaretha Stålhammar-Carlemalm, and Gunnar Lindahl
October 2009, PloS one,
Mattias C U Gustafsson, and Jonas Lannergård, and O Rickard Nilsson, and Bodil M Kristensen, and John E Olsen, and Claire L Harris, and Rafael L Ufret-Vincenty, and Margaretha Stålhammar-Carlemalm, and Gunnar Lindahl
April 2013, Cellular microbiology,
Mattias C U Gustafsson, and Jonas Lannergård, and O Rickard Nilsson, and Bodil M Kristensen, and John E Olsen, and Claire L Harris, and Rafael L Ufret-Vincenty, and Margaretha Stålhammar-Carlemalm, and Gunnar Lindahl
January 1989, Infection and immunity,
Mattias C U Gustafsson, and Jonas Lannergård, and O Rickard Nilsson, and Bodil M Kristensen, and John E Olsen, and Claire L Harris, and Rafael L Ufret-Vincenty, and Margaretha Stålhammar-Carlemalm, and Gunnar Lindahl
June 2007, Infection and immunity,
Mattias C U Gustafsson, and Jonas Lannergård, and O Rickard Nilsson, and Bodil M Kristensen, and John E Olsen, and Claire L Harris, and Rafael L Ufret-Vincenty, and Margaretha Stålhammar-Carlemalm, and Gunnar Lindahl
February 1997, Infection and immunity,
Mattias C U Gustafsson, and Jonas Lannergård, and O Rickard Nilsson, and Bodil M Kristensen, and John E Olsen, and Claire L Harris, and Rafael L Ufret-Vincenty, and Margaretha Stålhammar-Carlemalm, and Gunnar Lindahl
January 1997, Advances in experimental medicine and biology,
Mattias C U Gustafsson, and Jonas Lannergård, and O Rickard Nilsson, and Bodil M Kristensen, and John E Olsen, and Claire L Harris, and Rafael L Ufret-Vincenty, and Margaretha Stålhammar-Carlemalm, and Gunnar Lindahl
May 2003, European journal of biochemistry,
Mattias C U Gustafsson, and Jonas Lannergård, and O Rickard Nilsson, and Bodil M Kristensen, and John E Olsen, and Claire L Harris, and Rafael L Ufret-Vincenty, and Margaretha Stålhammar-Carlemalm, and Gunnar Lindahl
April 2003, Cellular microbiology,
Mattias C U Gustafsson, and Jonas Lannergård, and O Rickard Nilsson, and Bodil M Kristensen, and John E Olsen, and Claire L Harris, and Rafael L Ufret-Vincenty, and Margaretha Stålhammar-Carlemalm, and Gunnar Lindahl
January 1976, Allergie und Immunologie,
Copied contents to your clipboard!